COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 623: Articles 6221-6230  | Next

Natural variations within the glycan shield of SARS-CoV-2 impact viral spike dynamics
Newby, M. L., Fogarty, C. A., Allen, J. D., Butler, J., Fadda, E., Crispin, M.
10.1101/2022.08.17.504157 — Posted: 2022-08-17
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Wamhoff, E.-C., Ronsard, L., Feldman, J., Hauser, B. M., Knappe, G. A., Romanov, A., Lam, E., St. Denis, K., Balazs, A. B., Schmidt, A., Lingwood, D., Bathe, M.
10.1101/2022.08.16.504128 — Posted: 2022-08-17
Antigen Specific T Cells in People with Obesity at Five Months Following ChAdOx1 COVID-19 Vaccination
Wrigley-Kelly, N. E., DeBarra, C., Shaamile, F., Holland, A., Shaw, L., Mallon, P. W. G., O'Connell, J., Hogan, A. E., O'Shea, D.
10.1101/2022.08.16.22278821 — Posted: 2022-08-17
Impact of the COVID-19 pandemic on the socioeconomic inequality of health behavior among Japanese adolescents: a two-year-repeated cross-sectional survey
Kyan, A., Takakura, M.
10.1101/2022.08.11.22278499 — Posted: 2022-08-17
Long-term changes in human mobility responses to COVID-19-related information in Japan
Fukui, S.
10.1101/2022.08.15.22278703 — Posted: 2022-08-17
The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys
Giorgi Rossi, P., Carrozzi, G., Falini, P., Sampaolo, L., Gorini, G., Zorzi, M., Armaroli, P., Senore, C., Sassoli de Bianchi, P., Masocco, M., Zappa, M., Battisti, F., Mantellini, P.
10.1101/2022.08.15.22278787 — Posted: 2022-08-17
Revealing geographic transmission pattern of COVID-19 using neighborhood-level simulation with human mobility data and SEIR model: A Case Study of South Carolina
Ning, H., Li, Z., Qiao, S., Zeng, C., Zhang, J., Olatosi, B., Li, X.
10.1101/2022.08.16.22278809 — Posted: 2022-08-17
Rapid waning of protection induced by prior BA.1/BA.2 infection against BA.5 infection
Malato, J., Ribeiro, R. M., Fernandes, E., Pinto-Leite, P., Casaca, P., Antunes, C., Fonseca, V. R., Gomes, M. C., Graca, L.
10.1101/2022.08.16.22278820 — Posted: 2022-08-17
Comparative Analysis of Reported Deaths Cases Associated with the New Coronavirus COVID-19 Pandemic in the South Caucasus Countries (Armenia, Azerbaijan, Georgia) from March 2020 to May 2022
Amiranashvili, A. G., Khazaradze, K. R., Japaridze, N. D.
10.1101/2022.08.14.22278754 — Posted: 2022-08-17
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER program
Hill, E. L., Mehta, H. B., Sharma, S., Mane, K., Xie, C., Cathey, E., Loomba, J., Russell, S., Spratt, H., DeWitt, P. E., Ammar, N., Madlock-Brown, C., Brown, D., McMurry, J. A., Chute, C. G., Haendel, M. A., Moffitt, R., Pfaff, E. R., Bennett, T. D., The N3C Consortium, , The RECOVER Consortium
10.1101/2022.08.15.22278603 — Posted: 2022-08-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).